Use of Next Generation Technology for Proper Enteral Nutrition Feeding to Drive Global Enteral Medical Nutrition Market During 2022-2028

According to our latest study on "Enteral Medical Nutrition Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Indication, Nutrition Type, Form, Product, Distribution Channel, and Age Group," the market is expected to grow from US$ 7,803.45 million in 2021 to US$ 11,726.37 million by 2028; it is estimated to grow at a CAGR of 6.0% from 2022 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the market is primarily attributed to the increase in prevalence of cachexia in patients and rise in prevalence of gastrointestinal diseases. However, the complications related to enteral nutrition hamper the market growth.

Use of Next Generation Technology for Proper Enteral Nutrition Feeding

In enteral feeding, it is important to calculate patient's daily and cumulative energy balance, as it helps doctor plan the feeding routing according to the need of patient and decrease the morbidity and mortality risk among the patients. It is also essential to maintain the nutrient supply after discharge. There is no proper technology or equipment available for calculating the patient's daily and cumulative energy balance. Researchers are now focusing on the use of artificial intelligence (AI) and prediction algorithms for the development of technology that can be used to handle caloric and protein deficit and monitor the energy balance. The next generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy, and protein and vitamins deficits. Similar approach could overcome the deficits in the post ICU period. The implementation of next generation technology-based tools in the critical stage could help to ensure that a patient's nutritional plan and goals are constantly measured, monitored, and achieved. In addition, wearable data could be integrated with Electronic Health Record (EHR) data, including data from sensors continuously measuring physical activity and glucose level. The growing fields of metabolomics and proteomics hold the potential to assess nutritional status, set appropriate adjustments of the nutrient mix, and monitor progress through various stages of illness. Therefore, the use of AI, prediction analytics, metabolomics and proteomics, and many next generation technologies in enteral medical nutrition for proper feeding routine is expected to create lucrative growth opportunities for the enteral medical nutrition market during the forecast period.

Abbott Laboratories; Nutricia; Fresenius Kabi AG; B. Braun Melsungen AG; NESTLE S.A.; Meiji Holdings Co., Ltd.; Smartfish AS; DSM; Hormel Foods Corporation; and Global Health Products, Inc. are among the leading companies operating in the global enteral medical nutrition market.

Based on indication, the enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. The market for the respiratory disorders segment is further segmented into chronic obstructive pulmonary diseases, respiratory failure, cystic fibrosis, and others. The market for the cancer segment is subsegmented into cancer cachexia, cachexia withh COPD, and others. The market for the gastrointestinal disorders is further segmented into bowel obstruction, Crohn's disease, short bowel syndrome, and others.

Based on nutrition type, the enteral medical nutrition market is bifurcated into supplemental and sole-source. By form, the market is segmented into powder, liquid, and semi-solid. By product, the market is segmented into standard protein diet, high protein diet, fruit juice based oral nutritional supplement, and others. Based on distribution channel, the enteral medical nutrition market is segmented into hospital pharmacies, retail stores, and others. By age group, the market is bifurcated into child (till 18 years) and adults (18+years).

By geography, the global enteral medical nutrition market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com